2-(4-(3,4-dichlorophenylsulfonamido)phenyl)-N-(methylsulfonyl)acetamide

ID: ALA4533946

PubChem CID: 155546929

Max Phase: Preclinical

Molecular Formula: C15H14Cl2N2O5S2

Molecular Weight: 437.33

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)NC(=O)Cc1ccc(NS(=O)(=O)c2ccc(Cl)c(Cl)c2)cc1

Standard InChI:  InChI=1S/C15H14Cl2N2O5S2/c1-25(21,22)19-15(20)8-10-2-4-11(5-3-10)18-26(23,24)12-6-7-13(16)14(17)9-12/h2-7,9,18H,8H2,1H3,(H,19,20)

Standard InChI Key:  HUTZPFRSAVKWGC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 27  0  0  0  0  0  0  0  0999 V2000
    5.2870   -7.7179    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1042   -7.7220    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.6991   -7.0123    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5227   -2.9262    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9354   -3.6361    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.3439   -2.9237    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8141   -4.0488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5218   -3.6402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2295   -4.0488    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5218   -2.8230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6449   -4.0488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8141   -4.8660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1040   -5.2727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1037   -6.0892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8119   -6.4986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5220   -6.0856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5189   -5.2705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8130   -7.3158    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1070   -8.5425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4010   -8.9497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4017   -9.7662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1105  -10.1746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8200   -9.7607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8158   -8.9456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1127  -10.9918    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.6944  -10.1753    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  5  4  2  0
  6  5  2  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
  9  5  1  0
  5 11  1  0
  7 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 15 18  1  0
 18  2  1  0
  2 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 22 25  1  0
 21 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4533946

    ---

Associated Targets(Human)

SCN9A Tclin Sodium channel protein type IX alpha subunit (8393 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 437.33Molecular Weight (Monoisotopic): 435.9721AlogP: 2.41#Rotatable Bonds: 6
Polar Surface Area: 109.41Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 4.03CX Basic pKa: CX LogP: 1.98CX LogD: 0.90
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.72Np Likeness Score: -1.69

References

1. DiMauro EF, Altmann S, Berry LM, Bregman H, Chakka N, Chu-Moyer M, Bojic EF, Foti RS, Fremeau R, Gao H, Gunaydin H, Guzman-Perez A, Hall BE, Huang H, Jarosh M, Kornecook T, Lee J, Ligutti J, Liu D, Moyer BD, Ortuno D, Rose PE, Schenkel LB, Taborn K, Wang J, Wang Y, Yu V, Weiss MM..  (2016)  Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors.,  59  (17): [PMID:27441383] [10.1021/acs.jmedchem.6b00425]

Source